EUVIMEDEUVIMED entdecken
Crossref

Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation

Ashton A Connor iD, Mahinur Mattohti iD, Sudha Kodali iD, Maen Abdelrahim iD, Ahmed Elaileh iD, Samar Semaan iD, Constance M Mobley iD, Caroline J Simon iD, Yee Lee Cheah iD, Ashish Saharia iD, Sadhna Dhingra, Mary R Schwartz iD und 8 weitere

JCO Precision Oncology · 2026-03 · 10 (3)

DOI: 10.1200/po-25-00691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-03. Verfasst von Ashton A Connor und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Houston Methodist Hospital, Houston, TX. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Liver Transplantation, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Cholangiocarcinoma (CCA) has rising incidence and mortality rates. Liver transplantation (LT) offers good outcomes. Tumor molecular profiling may inform peri-LT treatment. MATERIALS AND METHODS Patients with CCA who underwent LT at a single center between 2014 and 2021 were identified retrospectively. Next-generation sequencing (277 genes) was performed on 28 CCAs from 18 patients, including five perihilar and 24 intrahepatic tumors. RESULTS Mutations were reported in 45 genes, most frequently IDH1 (5 patients), BAP1 (5), and TP53 (4). BAP1 was associated with neoadjuvant treatment response. Altered genes were organized into five pathways, namely: kinase-RAS (11 patients), TP53 (9), epigenetic (8), SWI-SNF (7) and RB-cell cycle (4). Both TP53 and RB-cell cycle pathway alterations were prognostic. Tumors were clustered into three groups, named here as cell cycle (seven patients), genomic instability (6), and cell survival (5). The latter had no post-transplant deaths. In 18 serially sequenced tumors from eight patients, mutational heterogeneity over time was quantified by Jaccard Index. This reflected both external selection pressures by systemic therapies and intrinsic tumor biology, being the lowest in cell survival tumors. Pathway- and subtype-level changes were rare. CONCLUSION In this LT cohort, CCA molecular profiling informed prognosis and treatment response. Heterogeneity may depend on early tumorigenesis disruptions, potentially explaining outcome differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaLiver TransplantationBile Duct NeoplasmsHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisMutationAgedHigh-Throughput Nucleotide SequencingTreatment Outcome

Autor:innen und Institutionen

  • Department of Surgery, Houston Methodist Hospital, Houston, TX.
  • JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, TX.
  • Department of Surgery, Weill Cornell Medical College, New York, NY.
  • Immunobiology and Transplant Science Center, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX.
  • Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX.
  • Department of Medicine, Weill Cornell Medical College, New York, NY.

ORCID-Profile: Ashton A Connor, Mahinur Mattohti, Sudha Kodali, Maen Abdelrahim, Ahmed Elaileh, Samar Semaan, Constance M Mobley, Caroline J Simon, Yee Lee Cheah, Ashish Saharia, Mary R Schwartz, Linda W Moore, Kirk Heyne, David W Victor, Xian C Li, Jean-Nicolas Vauthey, Milind Javle, A Osama Gaber, R Mark Ghobrial

Zitieren

APA

Connor, A. A., Mattohti, M., Kodali, S., Abdelrahim, M., Elaileh, A., Semaan, S., Mobley, C. M., Simon, C. J., Cheah, Y. L., Saharia, A., Dhingra, S., Schwartz, M. R., Moore, L. W., Heyne, K., Victor, D. W., Li, X. C., Vauthey, J. N., Javle, M., Gaber, A. O., & Ghobrial, R. M. (2026). Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation. JCO Precision Oncology, 10(3). https://doi.org/10.1200/po-25-00691

Vancouver

Connor AA, Mattohti M, Kodali S, Abdelrahim M, Elaileh A, Semaan S, et al. Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation. JCO Precision Oncology. 2026;10(3). doi:10.1200/po-25-00691

BibTeX
@article{Connor2026,
  author = {Connor, Ashton A and Mattohti, Mahinur and Kodali, Sudha and Abdelrahim, Maen and Elaileh, Ahmed and Semaan, Samar and Mobley, Constance M and Simon, Caroline J and Cheah, Yee Lee and Saharia, Ashish and Dhingra, Sadhna and Schwartz, Mary R and Moore, Linda W and Heyne, Kirk and Victor, David W and Li, Xian C and Vauthey, Jean-Nicolas and Javle, Milind and Gaber, A Osama and Ghobrial, R Mark},
  title = {Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {3},
  doi = {10.1200/po-25-00691}
}
Kostenlos starten →